Weinerman Bennett, Kwon Soon Bin, Alalqum Tammam, Nametz Daniel, Megjhani Murad, Clark Eunice, Varner Caleb, Cheung Eva W, Park Soojin
Program for Hospital and Intensive Care Informatics, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, USA.
Department of Pediatrics, Division of Critical Care & Hospital Medicine, Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian Morgan Stanley Children's Hospital, New York, USA.
medRxiv. 2024 Oct 18:2024.10.17.24315712. doi: 10.1101/2024.10.17.24315712.
Pediatric Veno-Arterial Extra Corporeal Membrane Oxygenation (VA ECMO) is a life saving technology associated with high mortality. A successful VA ECMO course requires attention to multiple aspects of patient care, including ECMO and patient parameters. Early, potentially modifiable, risk factors associated with patient mortality should be analyzed and adjusted for when assessing VA ECMO risk profiles.
Retrospective single center experience of pediatric patients requiring VA ECMO from January 2021 to October 2023. Laboratory and ECMO flow parameters were extracted from the patients record and analyzed. Risk factors were analyzed using a Cox proportion hazard regression.
There were 45 patients studied. Overall survival was 51%. Upon uncorrected analysis there were no significant differences between the patients who survived and those who died. Utilizing a Cox proportion hazard regression, platelet count, fibrinogen level and creatine level were significant risk factors within the first twenty-four hours of a patient's ECMO course.
Although we did not find a significant difference among ECMO flow parameters in this study, this work highlights that granular ECMO flow data can be incorporated to risk analysis profiles and potential modeling in pediatric VA ECMO. This study demonstrated, that when controlling for ECMO flow parameters, kidney dysfunction and clotting regulation remain key risk factors for pediatric VA ECMO mortality.
小儿静脉-动脉体外膜肺氧合(VA ECMO)是一项挽救生命的技术,但死亡率较高。成功的VA ECMO治疗过程需要关注患者护理的多个方面,包括ECMO和患者参数。在评估VA ECMO风险概况时,应分析并调整与患者死亡率相关的早期、可能可改变的风险因素。
回顾性单中心研究2021年1月至2023年10月期间需要VA ECMO的小儿患者。从患者记录中提取实验室和ECMO流量参数并进行分析。使用Cox比例风险回归分析风险因素。
共研究了45例患者。总体生存率为51%。未经校正分析时,存活患者和死亡患者之间无显著差异。利用Cox比例风险回归分析,血小板计数、纤维蛋白原水平和肌酸水平是患者ECMO治疗过程最初24小时内的显著风险因素。
尽管本研究未发现ECMO流量参数之间存在显著差异,但这项工作强调,详细的ECMO流量数据可纳入小儿VA ECMO的风险分析概况和潜在模型。本研究表明,在控制ECMO流量参数时,肾功能不全和凝血调节仍然是小儿VA ECMO死亡率的关键风险因素。